FDA Denies Citizen Petition To Amend OTC Topical Drugs Monograph
This article was originally published in The Tan Sheet
Executive Summary
FDA cites insufficient evidence in rejecting a citizen petition filed by a New Jersey podiatrist to amend the proposed monograph for topical OTC First Aid Antibiotic Drug Products
You may also be interested in...
Topical antibiotics
Inclusion of bacitracin/polymyxin/vitamin E/mixed oils ointment in OTC monograph requested by New Jersey podiatrist in citizen petition to FDA. Petition asks agency to lower required dosages of bacitracin, polymyxin and allow distribution of combo containing polymyxin B-sulfate (892 units/g of finished product), bacitracin zinc (44.05 units/g), vitamin E (141 IU/g) and blend of paraffin, fragrance, mineral oil, cod liver oil, lanolin and petrolatum...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands